Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent

来源 :第十二届中国介入心脏病学大会(CIT2014) | 被引量 : 0次 | 上传用户:liongliong471
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background TARGET Ⅰ randomized controlled trial demonstrated that the novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent FIREHAWK (MicroPort Medical,Shanghai,China) was non-inferior to the everolimus-eluting stent with respect to in-stent late loss at 9 months for the treatment of single de novo coronary lesions.
其他文献
Background Recently,a chronic total occlusion (CTO) in the non-infarct-related artery (non-IRA) was reported as an independent predictor of clinical outcome in patients with acute ST-segment elevation
会议
Background Previous studies demonstrated higher rates of adverse cardiac events and restenosis in patients with small vessel disease.No large-scale clinical study of everolimus-eluting stents (EES) wa
会议
Background Treatment of drug-eluting stent in-stent restenosis (DES-ISR) is still challenging especially in diabetes patients.The intention of this subgroup analysis was to compare the safety and effe
会议
Background Myocardial fractional flow reserve (FFR) is an indispensable tool to identify individual coronary stenoses causing ischemia.Calculation of FFR from X-ray angiographic data alone may increas
会议
Background Bare metal (BMS) and drug-eluting stents (DES) have decreased the need of target vessel revascularization (TVR) in primary percutaneous coronary intervention (PPCI),at the expense of the ri
会议
Background Biodegradable polymer drug-eluting stents (BPDES) have been developed to address the risk of stent thrombosis.The EXCEL stent (JW Medical Systems,Weihai,China) features an abluminal PLA dru
会议
Background To evaluate the efficiency of thrombus aspiration during primary percutaneous coronary intervention (PCI) for acute ST-segment elevation myocardial infarction (STEMI).Methods Databases incl
会议
Background It is complicated and high-risk for percutaneous coronary intervention (PCI) to treat chronic total occlusion (CTO) cases even for experienced cardiologists.In the same time,crossing of CTO
会议
Background Previous studies comparing one-stent with two-stent strategies,for left main (LM) coronary bifurcation disease,demonstrated controversial results.This large sample and long-term follow-up s
会议
Background Recently,the SYNTAX Score Ⅱ (SS-Ⅱ) was developed in an attempt to individualize and help the decision-making process between PCI and CABG.However,there is a paucity of data regarding the ut
会议